Work

Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Provides Prolonged Clinical Benefit to Advanced Cutaneous T-Cell Lymphoma Patients: Updated Results of the Phase IIb Multicenter Clinical Trial.

Year: 2006

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v108.11.399.399

Authors: Madeleine Duvic, Youn H. Kim, Timothy M. Kuzel, Theresa R. Pacheco, Francine M. Foss, Sareeta Parker, Stanley R. Frankel, Cong Chen, Justin L. Ricker, Jean Marie Arduino, Sophia Randolph, Victoria M. Richon, Elise A. Olsen

Institutions: The University of Texas MD Anderson Cancer Center, Stanford University, Northwestern University, Yale Cancer Center, Yale University, Emory University, Merck & Co., Inc., Rahway, NJ, USA (United States), Duke University

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2555074252

FWCI: 1.059

Cites:

Cited by: 5

Related to: 10